Aerius MSD syrup quickly reduces symptoms of allergic rhinitis, urticaria (60ml)

Dosage form Bottle x 60ml
Specifications Desloratadine
Ingredient Schering

Ingredient

Composition informationContent
Desloratadine0.5mg/ml

Uses

Aerius is indicated in the following cases:

  • Quickly reduce symptoms related to allergic rhinitis, such as sneezing, runny nose and itchy nose, congestion/nasal congestion as well as itching, watery eyes, red eyes, itchy throat and cough. Learning

    After taken, the desloratadine selectively inhibits the peripheral H1 histamine receptor due to the absolutely non -absorbing drug into the central nervous system (CNS).

    Desloratadine does not seep into the central nervous system. With a dose of 5mg treatment/day, the drowsiness rate is not higher than the placebo. In a single -dose study, Desloratadine 5mg does not affect the standard assessment of flight performance including drowsiness or flight -related tasks.

    Supplemented for the existing classification of seasonal and year -round allergic rhinitis, can classify allergic rhinitis in another way such as non -continuous allergic rhinitis and prolonged allergic rhinitis depending on the time of symptoms. Allergic rhinitis is not continuously determined when symptoms appear 4 days/week and last> 4 weeks.

    pharmacokinetic

    can quantify the plasma concentration of desloratadine within 30 minutes using desloratadine. Desloratadine is well absorbed with the maximum concentration achieved after about 3 hours, the selling time of the end of the end is about 27 hours. The accumulation of desloratadine is suitable for the disposal time of the drug (about 27 hours) and the dose once a day. The bioavailability of desloratadine is proportional to the dose of 5mg to 20mg.

    Desloratadine is moderately cohesive (83% - 87%) with plasma proteins. There is no evidence of clinical accumulation after daily dosage (5mg to 20mg) in 14 days.

    The yeast has not been determined to be responsible for transforming the desloratadine, and so it has not completely excluded a few interactions with other drugs. In vivo studies with specific inhibitors CYP3A4 and CYP2D6 have shown that these yeasts are not important in the metabolism of desloratadine. Desloratadine does not inhibit CYP3A4 or CYP2D6 and nor a substrate or p-Glycoprotein inhibitor.

  • Before taking Aerius MSD syrup quickly reduces symptoms of allergic rhinitis, urticaria (60ml)

    How to use

    oral drugs. Can be used with or not at the same meal.

    Dosage

    adults and adolescents (12 years old)

    10ml (5mg) Aerius Siro, take 1 time/day to reduce symptoms related to allergic rhinitis (including non -continuous allergic rhinitis and prolonged allergic rhinitis) and urticaria.

    Children from 6 to 11 years old

    5ml (2.5mg) Aerius Siro, taken 1 time/day to reduce symptoms related to allergic rhinitis (including non -continuous allergic rhinitis and prolonged allergic rhinitis) and urticaria.

    children from 1 to 5 years old

    2.5ml (1.25mg) Aerius Siro, take 1 time/day to reduce symptoms related to allergic rhinitis (including non -continuous allergic rhinitis and prolonged allergic rhinitis) and urticaria.

    Children from 6 months to 11 months of age

    2ml (1mg) Aerius Siro, 1 time/day to reduce symptoms related to allergic rhinitis (including non -continuous allergic rhinitis and prolonged allergic rhinitis) and urticaria.

    Non -continuous allergic rhinitis (symptoms that appear 4 days/week and last> 4 weeks), can be treated continuously during exposure to allergens.

    What to do when overdose? Should treat symptoms and support treatment.

    On a multi -dose clinical study in adults and adolescents using desloratadine up to 45mg (9 times higher than the clinical dose) did not observe the clinical manifestation of the overdose.

    Desloratadine is not excreted through blood decomposition, it is unclear whether it is excreted through peritoneal diverges.

    What to do when forgetting 1 dose? However, if the time to relax with the next dose is too short, skip the dose and continue the calendar of the drug. Do not use double dose to compensate for missed dose.

    Side Effects

    When using Aerius 0.5mg/ml, you may experience unwanted effects (ADR).

    In clinical trials on children, Aerius Siro is used for 246 children from 6 months to 11 years old. In general, the adverse effect rate in children 2 to 11 years old in both groups using Aerius Siro and Placebo.

    In children and children from 6 to 23 months, the most common adverse effects are reported more than Placebo are diarrhea (3.7%), fever (2.3%) and insomnia (2.3%).

    In clinical trials with indications for allergic rhinitis and chronic hunting, with a dose of 5mg/day, the adverse effects caused by Aerius tablets are reported in 3% of patients and higher than patients using Placebo.

    The most common adverse effects with higher frequency than Placebo are fatigue (1.2%), dry mouth (0.8%), and headache (0.6%).

    During the circulation of desloratadine on the market, it is very rare for the hypersensory reaction (including anaphylaxis and rash), heart rate, chest drum, increased mental activity, epilepsy, drowsiness, increased liver enzymes, hepatitis and boosting bilirubin.

    When experiencing side effects of the drug, it is necessary to stop using and notify the doctor or go to the nearest medical facility for timely treatment.

    Warnings

    Before using Aerius 0.5mg/ml you need to read the user manual carefully and refer to the information below.

    Contraindicated

    Aerius 0.5mg/ml of contraindications in cases of hypersensitivity to the active ingredient or any ingredient of the drug.

    Precautions when using

    The safety and effectiveness of Aerius Siro in children under 6 months old.

    The ability to drive and operate machinery

    does not observe that it affects the ability to drive and operate machinery (see pharmacokinetic properties).

    Pregnancy and lactation

    generally do not see the fertility in mice with desloratadine doses 34 times higher than the clinical dose proposed for humans.

    No observations of monitoring or gene mutations in animal tests using desloratadine. Because there is no clinical data on the use of desloratadine during pregnancy, Aerius' safety has not been determined during pregnancy. Do not use Aerius during pregnancy unless the benefits are out of risk.

    Do not use Aerius for breastfeeding women due to desloratadine to be secreted into breast milk.

    Medicinal interaction

    does not observe drug interactions in clinical trials.

    Food or grapefruit juice does not affect the pharmacokinetics of the desloratadine.

    Drinking Aerius along with alcohol does not increase the risk of behavioral decline of alcohol (see pharmacological properties).

    Storage

    Store in a cool dry place, temperatures below 30 degrees c.

    Avoid direct sun exposure.

    To be out of reach of children.

    Keep the drug in the original packaging.

    Other drugs

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    count views

    Popular Keywords